Fast dissociating dopamine 2 receptor antagonists

Details for Australian Patent Application No. 2008214716 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Langlois, Xavier Jean Michel; Macdonald, Gregor James; BartolomeNebreda, Jose Manuel; Van Gool, Michiel Luc Maria

Agent Shelston IP

Pub. Number AU-A-2008214716

PCT Pub. Number WO2008/098892

Priority 07102222.2 13.02.07 EP

Filing date 11 February 2008

Wipo publication date 21 August 2008

International Classifications

C07D 237/20 (2006.01) Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

C07D 237/24 (2006.01) Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings

C07D 409/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

1 October 2009 PCT application entered the National Phase

  PCT publication WO2008/098892 Priority application(s): WO2008/098892

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008214724-Web service discovery method and apparatus using natural language queries

2008214712-Foam layer produced of a biodegradable polyester mixture